Recent News

Search by keywords:

and/or

Explore by tags:

527 News Items found

MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer

Friday, May 27, 2022

The findings could pave the way toward more targeted treatments for the disease.

Event

GSK dean and graduates in their caps and gowns

MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners

Friday, May 20, 2022

At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.

MSK scientists Andrew Kung and Elli Papaemmanouil

New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer

Wednesday, May 18, 2022

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.

8 Gerstner Sloan Kettering Students Prepare To Graduate

Monday, May 16, 2022

Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.

A Sensor Sniffs for Cancer, Using Artificial Intelligence

Thursday, May 12, 2022

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.

SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy

Wednesday, April 20, 2022

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.

With CryoEM, MSK Researchers Obtain Exquisite View of the Androgen Receptor — A Key Protein in Prostate Cancer

Wednesday, April 20, 2022

The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science

Memorial Sloan Kettering Cancer Center Announces The Starr Foundation Program for Discovery Science

Tuesday, April 19, 2022

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.